HomeInsightsStock Comparison

Biocon Ltd vs Sai Life Sciences Ltd Stock Comparison

Biocon Ltd vs Sai Life Sciences Ltd Stock Comparison

Last Updated on: Aug 09, 2025

Key Highlights

  • The Latest Trading Price of Biocon Ltd is ₹ 356.85 as of 07 Aug 13:53.
  • The P/E Ratio of Biocon Ltd changed from 43.4 on March 2020 to 40.4 on March 2025 . This represents a CAGR of -1.19% over 6 yearsThe P/E Ratio of Sai Life Sciences Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Biocon Ltd changed from ₹ 32472 crore on March 2020 to ₹ 40964 crore on March 2025 . This represents a CAGR of 3.95% over 6 yearsThe Market Cap of Sai Life Sciences Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Biocon Ltd for the Jun '25 is ₹ 4021 crore as compare to the Mar '25 revenue of ₹ 4474 crore. This represent the decline of -10.12% The revenue of Sai Life Sciences Ltd for the Jun '25 is ₹ 506.32 crore as compare to the Mar '25 revenue of ₹ 589.11 crore. This represent the decline of -14.05%.
  • The ebitda of Biocon Ltd for the Jun '25 is ₹ 828.6 crore as compare to the Mar '25 ebitda of ₹ 1135 crore. This represent the decline of -27.03% The ebitda of Sai Life Sciences Ltd for the Jun '25 is ₹ 130.84 crore as compare to the Mar '25 ebitda of ₹ 167.17 crore. This represent the decline of -21.73%.
  • The net profit of Biocon Ltd changed from ₹ 148.9 crore to ₹ 89.2 crore over 9 quarters. This represents a CAGR of -20.37% The net profit of Sai Life Sciences Ltd changed from ₹ 39.61 crore to ₹ 60.46 crore over 7 quarters. This represents a CAGR of 27.34% .
  • The Dividend Payout of Biocon Ltd changed from 69.72 % on March 2022 to 9.85 % on March 2025 . This represents a CAGR of -38.69% over 4 yearsThe Dividend Payout of Sai Life Sciences Ltd changed from 443.82 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Biocon Ltd

  • Biocon Limited is India's largest and fully-integrated, innovation-led biopharmaceutical company.
  • Biocon, with its key business verticals of Generics, Biosimilars, Research Services and Novel Biologics, has leveraged its affordable innovation model and scientific capabilities to develop and manufacture both small and large molecules at global scale for the benefit of patients.
  • At present, Company is engaged in the manufacture of biotechnology products and research services. Biocon Limited was incorporated in year 1978 as a joint venture between Biocon Biochemicals Limited of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw.
  • Biocon manufactured and exported enzymes to USA and Europe during the year 1979, as first of its kind.
  • In 1989, Unilever plc acquired the Biocon Biochemicals Limited in Ireland and merges it with its subsidiary, Quest International.

About Sai Life Sciences Ltd

  • Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited' as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
  • The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999.
  • Subsequently, the Company name was changed from Sai Dru Syn Laboratories Limited' to Sai Life Sciences Limited' dated December 16, 2003. Thereafter, the name of the Company was changed from Sai Life Sciences Limited' to Sai Advantium Pharma Limited' dated August 30, 2006 issued by the Registrar of Companies, Andhra Pradesh.
  • Subsequently, the Company name was changed from Sai Advantium Pharma Limited' to Sai Life Sciences Limited' and a fresh Certificate of Incorporation dated May 28, 2012 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.

Biocon Ltd News Hub

News

Biocon drops after Q1 PAT tumbles 95% YoY to Rs 31 cr

Profit before tax (PBT) dropped 91.5% to Rs 96.90 crore in Q1 FY26 compared with Rs 1145.5...

Read more

08 Aug 2025 10:28

News

Biocon Ltd slips for fifth straight session

Biocon Ltd dropped for a fifth straight session today. The stock is quoting at Rs 372.85, ...

Read more

05 Aug 2025 13:35

News

Biocon edges higher after biologics arm launches autoimmune treatment drug Nepexto in Australia

Nepexto will be promoted by Generic Health, BBL's local partner and a leading provider of ...

Read more

23 Jul 2025 10:33

News

Biocon arm gets USFDA approval for insulin, Kirsty

Kirsty is biosimiler to Novolog. It is a rapid-acting human insulin analog indicated to im...

Read more

16 Jul 2025 08:32

News

Biocon Ltd gains for third straight session

Biocon Ltd gained for a third straight session today. The stock is quoting at Rs 390, up 2...

Read more

15 Jul 2025 13:05

News

Biocon schedules board meeting

Biocon will hold a meeting of the Board of Directors of the Company on 7 August 2025. Powe...

Read more

09 Jul 2025 10:55

Sai Life Sciences Ltd News Hub

News

Sai Life Sciences to convene board meeting

Sai Life Sciences will hold a meeting of the Board of Directors of the Company on 7 August...

Read more

22 Jul 2025 10:46

News

Sai Life Sciences rises on completion of second phase expansion at Bidar facility

The new phase, which became operational on 19 June 2025, adds approximately 91 kL of produ...

Read more

20 Jun 2025 14:49

News

Board of Sai Life Sciences approves allotment of 19,000 equity shares under EOSP

The Board of Sai Life Sciences at its meeting held on 09 June 2025 has approved and allott...

Read more

09 Jun 2025 19:33

News

Sai Life Sciences allots 25,000 equity shares under ESOPs

Sai Life Sciences has allotted 25,000 equity shares under ESOPs on 13 May 2025. Powered by...

Read more

14 May 2025 09:28

News

Sai Life Sciences jumps after stellar results

EBITDA jumped 42% year-on-year (YoY) to Rs 425 crore in FY25. EBITDA margin improved to 25...

Read more

14 May 2025 16:16

News

Sai Life Sciences to announce Quarterly Result

Sai Life Sciences will hold a meeting of the Board of Directors of the Company on 13 May 2...

Read more

08 May 2025 11:19

SWOT Analysis Of Biocon Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sai Life Sciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Biocon Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Biocon Ltd and Sai Life Sciences Ltd

Which company has a larger market capitalization, Biocon Ltd or Sai Life Sciences Ltd?

Market cap of Biocon Ltd is 45,904 Cr while Market cap of Sai Life Sciences Ltd is 17,287 Cr

What are the key factors driving the stock performance of Biocon Ltd and Sai Life Sciences Ltd?

The stock performance of Biocon Ltd and Sai Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Biocon Ltd and Sai Life Sciences Ltd?

As of August 9, 2025, the Biocon Ltd stock price is INR ₹343.35. On the other hand, Sai Life Sciences Ltd stock price is INR ₹828.15.

How do dividend payouts of Biocon Ltd and Sai Life Sciences Ltd compare?

To compare the dividend payouts of Biocon Ltd and Sai Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions